Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for SGLT2 Inhibitor
Abstract Number: 557
MIND THE GAP! DON’T BE PH’OOLED BY THIS UNUSUAL PRESENTATION OF DIABETIC KETOACIDOSIS
SHM Converge 2021
Case Presentation: A 55-year-old man with poorly-controlled type II diabetes and coronary artery bypass graft one month previously presented with a three-day history of dyspnea, nausea, vomiting, and constipation. He had been started on empagliflozin/metformin HCl after his bypass. On presentation, his vital signs were remarkable for tachycardia. His exam was notable for mild left [...]
Abstract Number: 742
A Saccharin Case of Diabetic Ketoacidosis
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 62 YO woman with PMHx significant for type 2 DM, HTN, CAD with a previous MI, and OSA was recovering as expected from elective decompressive laminectomy. On POD 4 she developed nausea, confusion, and lethargy. The hospitalist service was consulted, prompting a metabolic work-up that suggested anion gap metabolic acidosis. There were [...]
Abstract Number: 756
A TALE OF TWO DISTURBANCES: UNMASKING A CASE OF SGLT-2 INHIBITOR-ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS
Hospital Medicine 2020, Virtual Competition
Case Presentation: An 89-year-old year old woman with a history of type II diabetes mellitus, insulin-naïve and well-controlled on a regimen of metformin, sitagliptin, and dapagliflozin, presented with 3 days of nausea, vomiting, and poor intake of food and liquids. She had recently been prescribed cephalexin for a suspected UTI. She reported a subacute history [...]
Abstract Number: 773
A CASE OF CANAGLIFLOZIN INDUCED EUGLYCEMIC DIABETIC KETOACIDOSIS: RARE BUT SIGNIFICANT
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 54 year-old woman with a past medical history of hypertension and Type 2 diabetes mellitus treated with metformin and canagliflozin presented to the hospital with lethargy and malaise. She reported that her blood glucose was stable over the past 2 weeks with fingerstick glucoses ranging from 100-130mg/ dL. She had been vomiting [...]
Abstract Number: J35
EMPAGLIFLOZIN-INDUCED PANCREATITIS: A CASE-REPORT PATTERN?
SHM Converge 2022
Case Presentation: A 73yo Caucasian female with history of hypertension, hyperlipidemia, type II diabetes mellitus, and osteoarthritis, presented a few hours after sudden onset, sharp LUQ abdominal pain associated with multiple episodes of nausea and vomiting. Patient denied any previous event like presentation. Further workup revealed no history of pancreatitis, trauma, or alcohol abuse. Medications [...]
Abstract Number: N46
NOT SO SWEET: A CASE OF MISSED EUGLYCEMIC DIABETIC KETOACIDOSIS
SHM Converge 2022
Case Presentation: A 60 year old female with small cell cancer, type 2 diabetes on an insulin pump and empagliflozin, and recently diagnosed pulmonary embolus (PE) on apixaban presents to the hospital with intractable nausea with vomiting and symptomatic tachycardia. This patient presented 1 month prior with dyspnea and tachycardia and was found to have [...]
Abstract Number: 1021
NEW INFORMATION FLOZ-IN: ACUTE PANCREATITIS AS A RARE SIDE EFFECT OF EMPAGLIFLOZIN
Hospital Medicine 2020, Virtual Competition
Case Presentation: A 51-year-old female presenting with increasing epigastric pain radiating to her back, nausea, and vomiting for five days. Her past medical history is relevant for coronary artery disease and CABG, type 2 diabetes, hypertension, prior tobacco use, and mood disorder. She had visited her primary care doctor the day prior to presentation with [...]
  • This Week

  • This Month

  • All Time

  • This Week

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • ADDERALL INDUCED ISCHEMIC COLITIS

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE

  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations

  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN

© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top